Opdivo 240 MG/24 ML vial 24ML
Ended Awarded Last action
- Contract number
- SPE2DR26FQT7V
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $132,440
Award facts
- Contract value 100% obligated
- $132,439.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $132,439.68 to AmerisourceBergen Drug Corp for the supply of OPDIVO 240 mg/24 mL vials. This firm fixed-price contract, issued on January 7, 2026, represents a non-set-aside competitive award with performance scheduled for completion by January 29, 2026. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which carries a potential value of $999,999,999.00 through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., functions as a critical pharmaceutical distributor for federal medical procurement, particularly supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contracting portfolio demonstrates extensive experience delivering brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. OPDIVO is an oncology medication used in cancer treatment, reflecting the company's significant role in supplying specialized pharmaceutical products to support military treatment facilities and veteran healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DR26FQT7V?
SPE2DR26FQT7V was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26FQT7V worth?
The government has obligated $132,440 on SPE2DR26FQT7V.
Is contract SPE2DR26FQT7V an order under another contract?
Yes. SPE2DR26FQT7V is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQT7V competed?
The extent of competition for SPE2DR26FQT7V was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award